---
schema_version: "secwatch.filing_event.v1"
accession: "0001787306-23-000109"
form_type: "8-K"
ticker: "ARQT"
cik: "0001787306"
company_name: "Arcutis Biotherapeutics, Inc."
filed_at: "2023-09-27T23:59:59+00:00"
generated_at: "2026-06-10T08:13:08.784175+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Arcutis appoints L. Todd Edwards as Chief Commercial Officer; Ayisha Jeter promoted

## Summary
- Edwards joins from Incyte with 25+ years in dermatology/immunology at UCB and AbbVie.
- He will lead ZORYVE cream launch for plaque psoriasis and prepare for future indications.
- Ayisha Jeter promoted to SVP Marketing and Market Access, reporting to Edwards.
- Edwards receives $500,016 base salary, 45% target bonus, equity grants of 240K options, 60K RSUs, 60K PSUs.

## SEC filing metadata
- accession: 0001787306-23-000109
- form_type: 8-K
- ticker: ARQT
- cik: 0001787306
- company_name: Arcutis Biotherapeutics, Inc.
- filed_at: 2023-09-27T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787306/000178730623000109/0001787306-23-000109-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787306/000178730623000109/arqt-20230927.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001787306-23-000109
- JSON: https://secwatch.observer/filing/0001787306-23-000109.json
- Plain text: https://secwatch.observer/filing/0001787306-23-000109.txt

## Key facts
- Executive change
  L. Todd Edwards was appointed as Chief Commercial Officer at Arcutis Biotherapeutics, Inc..
  - Action: appointed
  - Role: Chief Commercial Officer
  source text: On September 27, 2023, Arcutis Biotherapeutics, Inc. (the “Company” or “Arcutis”) announced the appointment of L. Todd Edwards as the Company’s Chief Commercial Officer, effective as of September 27, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787306/000178730623000109/0001787306-23-000109-index.htm
- Executive change
  Ayisha Jeter changed role as Senior Vice President, Marketing and Market Access at Arcutis Biotherapeutics, Inc..
  - Action: promoted
  - Role: Senior Vice President, Marketing and Market Access
  source text: In connection with the appointment of Mr. Edwards, Ms. Jeter will be promoted to Senior Vice President, Marketing and Market Access, effective as of September 27, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787306/000178730623000109/0001787306-23-000109-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.